Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 236

1.

Infrared Thermography for Estimating Supraclavicular Skin Temperature and BAT Activity in Humans: A Systematic Review.

Jimenez-Pavon D, Corral-Perez J, Sánchez-Infantes D, Villarroya F, Ruiz JR, Martinez-Tellez B.

Obesity (Silver Spring). 2019 Dec;27(12):1932-1949. doi: 10.1002/oby.22635. Epub 2019 Nov 5. Review.

PMID:
31691547
2.

Circulating growth-and-differentiation factor-15 in early life: relation to prenatal and postnatal growth and adiposity measurements.

Díaz M, Campderrós L, Guimaraes MP, López-Bermejo A, de Zegher F, Villarroya F, Ibáñez L.

Pediatr Res. 2019 Oct 23. doi: 10.1038/s41390-019-0633-z. [Epub ahead of print]

PMID:
31645058
3.

A role for Oncostatin M in the impairment of glucose homeostasis in obesity.

Piquer-Garcia I, Campderros L, Taxerås SD, Gavaldà-Navarro A, Pardo R, Vila M, Pellitero S, Martínez E, Tarascó J, Moreno P, Villarroya J, Cereijo R, González L, Reyes M, Rodriguez-Fernández S, Vives-Pi M, Lerin C, Elks CM, Stephens JM, Puig-Domingo M, Villarroya F, Villena JA, Sánchez-Infantes D.

J Clin Endocrinol Metab. 2019 Oct 13. pii: dgz090. doi: 10.1210/clinem/dgz090. [Epub ahead of print]

PMID:
31606738
4.

New insights into the secretory functions of brown adipose tissue.

Villarroya J, Cereijo R, Gavaldà-Navarro A, Peyrou M, Giralt M, Villarroya F.

J Endocrinol. 2019 Aug 1. pii: JOE-19-0295.R1. doi: 10.1530/JOE-19-0295. [Epub ahead of print] Review.

PMID:
31419785
5.

Brown Adipocytes Secrete GDF15 in Response to Thermogenic Activation.

Campderrós L, Moure R, Cairó M, Gavaldà-Navarro A, Quesada-López T, Cereijo R, Giralt M, Villarroya J, Villarroya F.

Obesity (Silver Spring). 2019 Oct;27(10):1606-1616. doi: 10.1002/oby.22584. Epub 2019 Aug 14.

PMID:
31411815
6.

GPR120 controls neonatal brown adipose tissue thermogenic induction.

Quesada-López T, Gavaldà-Navarro A, Morón-Ros S, Campderrós L, Iglesias R, Giralt M, Villarroya F.

Am J Physiol Endocrinol Metab. 2019 Nov 1;317(5):E742-E750. doi: 10.1152/ajpendo.00081.2019. Epub 2019 Jul 30.

PMID:
31361546
7.

Elevated Levels of Circulating miR-92a Are Associated with Impaired Glucose Homeostasis in Patients with Obesity and Correlate with Metabolic Status After Bariatric Surgery.

Cereijo R, Taxerås SD, Piquer-Garcia I, Pellitero S, Martínez E, Tarascó J, Moreno P, Balibrea J, Puig-Domingo M, Jiménez-Pavón D, Lerin C, Villarroya F, Sánchez-Infantes D.

Obes Surg. 2019 Jul 26. doi: 10.1007/s11695-019-04104-y. [Epub ahead of print]

PMID:
31346930
8.

Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study.

Casasnovas C, Ruiz M, Schlüter A, Naudí A, Fourcade S, Veciana M, Castañer S, Albertí A, Bargalló N, Johnson M, Raymond GV, Fatemi A, Moser AB, Villarroya F, Portero-Otín M, Artuch R, Pamplona R, Pujol A.

Neurotherapeutics. 2019 May 10. doi: 10.1007/s13311-019-00735-2. [Epub ahead of print]

PMID:
31077039
9.

Oral administration of a new HRI activator as a new strategy to improve high-fat-diet-induced glucose intolerance, hepatic steatosis, and hypertriglyceridaemia through FGF21.

Zarei M, Pujol E, Quesada-López T, Villarroya F, Barroso E, Vázquez S, Pizarro-Delgado J, Palomer X, Vázquez-Carrera M.

Br J Pharmacol. 2019 Jul;176(13):2292-2305. doi: 10.1111/bph.14678. Epub 2019 May 23.

PMID:
30927369
10.

Parkin controls brown adipose tissue plasticity in response to adaptive thermogenesis.

Cairó M, Campderrós L, Gavaldà-Navarro A, Cereijo R, Delgado-Anglés A, Quesada-López T, Giralt M, Villarroya J, Villarroya F.

EMBO Rep. 2019 May;20(5). pii: e46832. doi: 10.15252/embr.201846832. Epub 2019 Mar 13.

PMID:
30867164
11.

Secretory Proteome of Brown Adipocytes in Response to cAMP-Mediated Thermogenic Activation.

Villarroya J, Cereijo R, Giralt M, Villarroya F.

Front Physiol. 2019 Feb 7;10:67. doi: 10.3389/fphys.2019.00067. eCollection 2019.

12.

Nerve Growth Factor Levels in Term Human Infants: Relationship to Prenatal Growth and Early Postnatal Feeding.

Sánchez-Infantes D, Cereijo R, Sebastiani G, Pérez-Cruz M, Villarroya F, Ibáñez L.

Int J Endocrinol. 2018 Dec 23;2018:7562702. doi: 10.1155/2018/7562702. eCollection 2018.

13.

Fibroblast growth factor-21 protects against fibrosis in hypertensive heart disease.

Ferrer-Curriu G, Redondo-Angulo I, Guitart-Mampel M, Ruperez C, Mas-Stachurska A, Sitges M, Garrabou G, Villarroya F, Fernández-Solà J, Planavila A.

J Pathol. 2019 May;248(1):30-40. doi: 10.1002/path.5226. Epub 2019 Jan 30.

PMID:
30582148
14.

Antimicrobial promotion of pig growth is associated with tissue-specific remodeling of bile acid signature and signaling.

Ipharraguerre IR, Pastor JJ, Gavaldà-Navarro A, Villarroya F, Mereu A.

Sci Rep. 2018 Sep 12;8(1):13671. doi: 10.1038/s41598-018-32107-9.

15.

Brown adipose tissue in prepubertal children: associations with sex, birthweight, and metabolic profile.

Malpique R, Gallego-Escuredo JM, Sebastiani G, Villarroya J, López-Bermejo A, de Zegher F, Villarroya F, Ibáñez L.

Int J Obes (Lond). 2019 Feb;43(2):384-391. doi: 10.1038/s41366-018-0198-7. Epub 2018 Sep 5.

PMID:
30185921
16.

Low-Dose Spironolactone-Pioglitazone-Metformin Normalizes Circulating Fetuin-A Concentrations in Adolescent Girls with Polycystic Ovary Syndrome.

Díaz M, Gallego-Escuredo JM, López-Bermejo A, de Zegher F, Villarroya F, Ibáñez L.

Int J Endocrinol. 2018 Jul 19;2018:4192940. doi: 10.1155/2018/4192940. eCollection 2018.

17.

CXCL14, a Brown Adipokine that Mediates Brown-Fat-to-Macrophage Communication in Thermogenic Adaptation.

Cereijo R, Gavaldà-Navarro A, Cairó M, Quesada-López T, Villarroya J, Morón-Ros S, Sánchez-Infantes D, Peyrou M, Iglesias R, Mampel T, Turatsinze JV, Eizirik DL, Giralt M, Villarroya F.

Cell Metab. 2018 Nov 6;28(5):750-763.e6. doi: 10.1016/j.cmet.2018.07.015. Epub 2018 Aug 16.

18.

Aging is associated with increased FGF21 levels but unaltered FGF21 responsiveness in adipose tissue.

Villarroya J, Gallego-Escuredo JM, Delgado-Anglés A, Cairó M, Moure R, Gracia Mateo M, Domingo JC, Domingo P, Giralt M, Villarroya F.

Aging Cell. 2018 Oct;17(5):e12822. doi: 10.1111/acel.12822. Epub 2018 Jul 24.

19.

Inflammation of brown/beige adipose tissues in obesity and metabolic disease.

Villarroya F, Cereijo R, Gavaldà-Navarro A, Villarroya J, Giralt M.

J Intern Med. 2018 Nov;284(5):492-504. doi: 10.1111/joim.12803. Epub 2018 Jul 16. Review.

PMID:
29923291
20.

Toward an Understanding of How Immune Cells Control Brown and Beige Adipobiology.

Villarroya F, Cereijo R, Villarroya J, Gavaldà-Navarro A, Giralt M.

Cell Metab. 2018 May 1;27(5):954-961. doi: 10.1016/j.cmet.2018.04.006. Review.

21.

Lactate induces expression and secretion of fibroblast growth factor-21 by muscle cells.

Villarroya J, Campderros L, Ribas-Aulinas F, Carrière A, Casteilla L, Giralt M, Villarroya F.

Endocrine. 2018 Jul;61(1):165-168. doi: 10.1007/s12020-018-1612-6. Epub 2018 Apr 27. No abstract available.

PMID:
29704156
22.

Brown Adipokines.

Villarroya F, Gavaldà-Navarro A, Peyrou M, Villarroya J, Giralt M.

Handb Exp Pharmacol. 2019;251:239-256. doi: 10.1007/164_2018_119.

PMID:
29675584
23.

Reciprocal Effects of Antiretroviral Drugs Used To Treat HIV Infection on the Fibroblast Growth Factor 21/β-Klotho System.

Moure R, Domingo P, Villarroya J, Gasa L, Gallego-Escuredo JM, Quesada-López T, Morón-Ros S, Maroto AF, Mateo GM, Domingo JC, Villarroya F, Giralt M.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e00029-18. doi: 10.1128/AAC.00029-18. Print 2018 Jun.

24.

Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency.

Rodríguez-Nuevo A, Díaz-Ramos A, Noguera E, Díaz-Sáez F, Duran X, Muñoz JP, Romero M, Plana N, Sebastián D, Tezze C, Romanello V, Ribas F, Seco J, Planet E, Doctrow SR, González J, Borràs M, Liesa M, Palacín M, Vendrell J, Villarroya F, Sandri M, Shirihai O, Zorzano A.

EMBO J. 2018 May 15;37(10). pii: e96553. doi: 10.15252/embj.201796553. Epub 2018 Apr 9.

25.

Autophagic control of cardiac steatosis through FGF21 in obesity-associated cardiomyopathy.

Rupérez C, Lerin C, Ferrer-Curriu G, Cairo M, Mas-Stachurska A, Sitges M, Villarroya J, Giralt M, Villarroya F, Planavila A.

Int J Cardiol. 2018 Jun 1;260:163-170. doi: 10.1016/j.ijcard.2018.02.109. Epub 2018 Mar 5.

PMID:
29519677
26.

Effects of docosahexanoic acid supplementation on inflammatory and subcutaneous adipose tissue gene expression in HIV-infected patients on combination antiretroviral therapy (cART). A sub-study of a randomized, double-blind, placebo-controlled study.

Domingo P, Gallego-Escuredo JM, Fernández I, Villarroya J, Torres F, Del Mar Gutierrez M, Mateo MG, Villarroya F, Vidal F, Giralt M, Domingo JC.

Cytokine. 2018 May;105:73-79. doi: 10.1016/j.cyto.2018.02.008. Epub 2018 Feb 20.

PMID:
29471285
27.

Developmental regulation of the intestinal FGF19 system in domestic pigs.

Gavaldà-Navarro A, Pastor JJ, Mereu A, Villarroya F, Ipharraguerre IR.

Am J Physiol Gastrointest Liver Physiol. 2018 Jun 1;314(6):G647-G654. doi: 10.1152/ajpgi.00312.2017. Epub 2018 Feb 15.

28.

Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease.

Zarei M, Barroso E, Palomer X, Dai J, Rada P, Quesada-López T, Escolà-Gil JC, Cedó L, Zali MR, Molaei M, Dabiri R, Vázquez S, Pujol E, Valverde ÁM, Villarroya F, Liu Y, Wahli W, Vázquez-Carrera M.

Mol Metab. 2018 Feb;8:117-131. doi: 10.1016/j.molmet.2017.12.008. Epub 2017 Dec 19.

29.

The Lives and Times of Brown Adipokines.

Villarroya F, Gavaldà-Navarro A, Peyrou M, Villarroya J, Giralt M.

Trends Endocrinol Metab. 2017 Dec;28(12):855-867. doi: 10.1016/j.tem.2017.10.005. Epub 2017 Nov 4. Review.

PMID:
29113711
30.

Opposite changes in meteorin-like and oncostatin m levels are associated with metabolic improvements after bariatric surgery.

Pellitero S, Piquer-Garcia I, Ferrer-Curriu G, Puig R, Martínez E, Moreno P, Tarascó J, Balibrea J, Lerin C, Puig-Domingo M, Villarroya F, Planavila A, Sánchez-Infantes D.

Int J Obes (Lond). 2018 Apr;42(4):919-922. doi: 10.1038/ijo.2017.268. Epub 2017 Oct 30.

PMID:
29081506
31.

Loss of SIRT2 leads to axonal degeneration and locomotor disability associated with redox and energy imbalance.

Fourcade S, Morató L, Parameswaran J, Ruiz M, Ruiz-Cortés T, Jové M, Naudí A, Martínez-Redondo P, Dierssen M, Ferrer I, Villarroya F, Pamplona R, Vaquero A, Portero-Otín M, Pujol A.

Aging Cell. 2017 Dec;16(6):1404-1413. doi: 10.1111/acel.12682. Epub 2017 Oct 5.

32.

Liver volume and hepatic adiposity in childhood: relations to body growth and visceral fat.

Malpique R, Bassols J, López-Bermejo A, Diaz M, Villarroya F, Pavia J, Congo A, de Zegher F, Ibáñez L.

Int J Obes (Lond). 2018 Jan;42(1):65-71. doi: 10.1038/ijo.2017.198. Epub 2017 Aug 14.

PMID:
28925408
33.

Hypothalamic AMPK-ER Stress-JNK1 Axis Mediates the Central Actions of Thyroid Hormones on Energy Balance.

Martínez-Sánchez N, Seoane-Collazo P, Contreras C, Varela L, Villarroya J, Rial-Pensado E, Buqué X, Aurrekoetxea I, Delgado TC, Vázquez-Martínez R, González-García I, Roa J, Whittle AJ, Gomez-Santos B, Velagapudi V, Tung YCL, Morgan DA, Voshol PJ, Martínez de Morentin PB, López-González T, Liñares-Pose L, Gonzalez F, Chatterjee K, Sobrino T, Medina-Gómez G, Davis RJ, Casals N, Orešič M, Coll AP, Vidal-Puig A, Mittag J, Tena-Sempere M, Malagón MM, Diéguez C, Martínez-Chantar ML, Aspichueta P, Rahmouni K, Nogueiras R, Sabio G, Villarroya F, López M.

Cell Metab. 2017 Jul 5;26(1):212-229.e12. doi: 10.1016/j.cmet.2017.06.014.

34.

Effects of docosahexanoic acid on metabolic and fat parameters in HIV-infected patients on cART: A randomized, double-blind, placebo-controlled study.

Domingo P, Fernández I, Gallego-Escuredo JM, Torres F, Gutierrez MDM, Mateo MG, Villarroya J, Giralt M, Vidal F, Villarroya F, Domingo JC.

Clin Nutr. 2018 Aug;37(4):1340-1347. doi: 10.1016/j.clnu.2017.05.032. Epub 2017 Jun 8.

PMID:
28648475
35.

High FGF21 levels are associated with altered bone homeostasis in HIV-1-infected patients.

Gallego-Escuredo JM, Lamarca MK, Villarroya J, Domingo JC, Mateo MG, Gutierrez MDM, Vidal F, Villarroya F, Domingo P, Giralt M.

Metabolism. 2017 Jun;71:163-170. doi: 10.1016/j.metabol.2017.03.014. Epub 2017 Mar 31.

PMID:
28521869
36.

Fgf21 is required for cardiac remodeling in pregnancy.

Redondo-Angulo I, Mas-Stachurska A, Sitges M, Tinahones FJ, Giralt M, Villarroya F, Planavila A.

Cardiovasc Res. 2017 Nov 1;113(13):1574-1584. doi: 10.1093/cvr/cvx088.

PMID:
28472473
37.

Cardiokines as Modulators of Stress-Induced Cardiac Disorders.

Planavila A, Fernández-Solà J, Villarroya F.

Adv Protein Chem Struct Biol. 2017;108:227-256. doi: 10.1016/bs.apcsb.2017.01.002. Epub 2017 Feb 10. Review.

PMID:
28427562
38.

Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration.

Alvarez-Sola G, Uriarte I, Latasa MU, Fernandez-Barrena MG, Urtasun R, Elizalde M, Barcena-Varela M, Jiménez M, Chang HC, Barbero R, Catalán V, Rodríguez A, Frühbeck G, Gallego-Escuredo JM, Gavaldà-Navarro A, Villarroya F, Rodriguez-Ortigosa CM, Corrales FJ, Prieto J, Berraondo P, Berasain C, Avila MA.

Gut. 2017 Oct;66(10):1818-1828. doi: 10.1136/gutjnl-2016-312975. Epub 2017 Jan 24.

PMID:
28119353
39.

The lipid sensor GPR120 promotes brown fat activation and FGF21 release from adipocytes.

Quesada-López T, Cereijo R, Turatsinze JV, Planavila A, Cairó M, Gavaldà-Navarro A, Peyrou M, Moure R, Iglesias R, Giralt M, Eizirik DL, Villarroya F.

Nat Commun. 2016 Nov 17;7:13479. doi: 10.1038/ncomms13479.

40.

Brown adipose tissue as a secretory organ.

Villarroya F, Cereijo R, Villarroya J, Giralt M.

Nat Rev Endocrinol. 2017 Jan;13(1):26-35. doi: 10.1038/nrendo.2016.136. Epub 2016 Sep 12. Review.

PMID:
27616452
41.

Histone macroH2A1.2 promotes metabolic health and leanness by inhibiting adipogenesis.

Pazienza V, Panebianco C, Rappa F, Memoli D, Borghesan M, Cannito S, Oji A, Mazza G, Tamburrino D, Fusai G, Barone R, Bolasco G, Villarroya F, Villarroya J, Hatsuzawa K, Cappello F, Tarallo R, Nakanishi T, Vinciguerra M.

Epigenetics Chromatin. 2016 Oct 25;9:45. eCollection 2016.

42.

Oncostatin m impairs brown adipose tissue thermogenic function and the browning of subcutaneous white adipose tissue.

Sánchez-Infantes D, Cereijo R, Peyrou M, Piquer-Garcia I, Stephens JM, Villarroya F.

Obesity (Silver Spring). 2017 Jan;25(1):85-93. doi: 10.1002/oby.21679. Epub 2016 Oct 5.

43.

Hormonal and nutritional signalling in the control of brown and beige adipose tissue activation and recruitment.

Giralt M, Cairó M, Villarroya F.

Best Pract Res Clin Endocrinol Metab. 2016 Aug;30(4):515-525. doi: 10.1016/j.beem.2016.08.005. Epub 2016 Aug 15. Review.

PMID:
27697212
44.

Transcriptional regulation of the uncoupling protein-1 gene.

Villarroya F, Peyrou M, Giralt M.

Biochimie. 2017 Mar;134:86-92. doi: 10.1016/j.biochi.2016.09.017. Epub 2016 Oct 5. Review.

PMID:
27693079
45.

Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma.

Jueliger S, Lyons J, Cannito S, Pata I, Pata P, Shkolnaya M, Lo Re O, Peyrou M, Villarroya F, Pazienza V, Rappa F, Cappello F, Azab M, Taverna P, Vinciguerra M.

Epigenetics. 2016 Oct 2;11(10):709-720. doi: 10.1080/15592294.2016.1214781. Epub 2016 Sep 20.

46.

Heme-Regulated eIF2α Kinase Modulates Hepatic FGF21 and Is Activated by PPARβ/δ Deficiency.

Zarei M, Barroso E, Leiva R, Barniol-Xicota M, Pujol E, Escolano C, Vázquez S, Palomer X, Pardo V, González-Rodríguez Á, Valverde ÁM, Quesada-López T, Villarroya F, Wahli W, Vázquez-Carrera M.

Diabetes. 2016 Oct;65(10):3185-99. doi: 10.2337/db16-0155. Epub 2016 Aug 2.

47.

Angiopoietin-like protein 8 (ANGPTL8) in pregnancy: a brown adipose tissue-derived endocrine factor with a potential role in fetal growth.

Martinez-Perez B, Ejarque M, Gutierrez C, Nuñez-Roa C, Roche K, Vila-Bedmar R, Ballesteros M, Redondo-Angulo I, Planavila A, Villarroya F, Vendrell J, Fernández-Veledo S, Megía A.

Transl Res. 2016 Dec;178:1-12. doi: 10.1016/j.trsl.2016.06.012. Epub 2016 Jul 9.

PMID:
27469268
48.

Lipopolysaccharide-binding protein is a negative regulator of adipose tissue browning in mice and humans.

Gavaldà-Navarro A, Moreno-Navarrete JM, Quesada-López T, Cairó M, Giralt M, Fernández-Real JM, Villarroya F.

Diabetologia. 2016 Oct;59(10):2208-18. doi: 10.1007/s00125-016-4028-y. Epub 2016 Jun 25.

PMID:
27344313
49.

Thermogenic activation represses autophagy in brown adipose tissue.

Cairó M, Villarroya J, Cereijo R, Campderrós L, Giralt M, Villarroya F.

Int J Obes (Lond). 2016 Oct;40(10):1591-1599. doi: 10.1038/ijo.2016.115. Epub 2016 Jun 24.

PMID:
27339605
50.

Impact of elvitegravir on human adipocytes: Alterations in differentiation, gene expression and release of adipokines and cytokines.

Moure R, Domingo P, Gallego-Escuredo JM, Villarroya J, Gutierrez Mdel M, Mateo MG, Domingo JC, Giralt M, Villarroya F.

Antiviral Res. 2016 Aug;132:59-65. doi: 10.1016/j.antiviral.2016.05.013. Epub 2016 May 20.

PMID:
27216995

Supplemental Content

Loading ...
Support Center